← Leaderboards
Michael D Kaytor
Humanetics Corporation
$2,888,484
Attributed
$3,299,457
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2014–23$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,299,457 · 4
By mechanism
N01$2,179,037 · 1
R43$895,529 · 2
R41$224,891 · 1
Top collaborators
- Isabel Lauren Jackson2 shared
- Zeljko Vujaskovic1 shared
Most similar at Humanetics Corporation
Same institution · by research overlap
- Isabel Lauren Jackson$7,555,426
- John L. Zenk$600,000
- Michael Kaytor$6,012,882
Others in their field
Top investigators on “Radiation”
- Philip J Disaia · University Of California Irvine$135,204,929
- Walter John Curran · Thomas Jefferson University$132,574,833
- Richard L Schilsky · University Of Chicago$122,521,723
- Polly Chang · Sri International$120,948,376
- Maury Tigner · Cornell University$104,613,212
- Norman Wolmark · Nsabp Foundation, Inc.$104,551,329
Research focus
RadiationTissuesEffective TherapyPreventGenisteinPulmonary FibrosisLung InjuryFutureAdvanced DevelopmentPulmonary InflammationInjuryLungInflammatoryExposure ToOralLifeChestDoseSuspensionsAnimal EfficacyAntioxidantsAnti-Inflammatory AgentsAnti-InflammatoryHistopathology
Grant awards (5)
Development of BIO 300 as a novel treatment for idiopathic pulmonary fibrosis$298,474
R43 · FY2023 · HL · contact PI
AN NHP EFFICACY STUDY OF BIO 300 FOR MITIGATOR FOR DEARE-INDUCED PNEUMONITIS AND PULMONARY FIBROSIS$2,179,037
N01 · FY2019 · AI · contact PI
Development of BIO 300 as a MCM for lethal radiation pneumonitis/fibrosis$298,020
R43 · FY2017 · AI · contact PI
Development of BIO 300 as a MCM for lethal radiation pneumonitis/fibrosis$299,035
R43 · FY2016 · AI · contact PI
Prevention of erectile dysfunction following prostate cancer radiotherapy$224,891
R41 · FY2014 · CA · contact PI